Balyasny Asset Management »

Structure Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $15M 305k 48.20
2025-12-31 $15M 216k 69.55
2025-09-30 $13M 462k 28.00
2025-03-31 $3.5M 203k 17.31
2023-09-30 $677k 13k 50.42

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Structure Therapeutics

FMR
Wellington Management Company
venBio Select Advisor
Henderson Group
Deep Track Capital
BVF
Morgan Stanley
Principal Financial Group
Driehaus Capital Management
OrbiMed Advisors
Baker Bros. Advisors
Casdin Capital
Capitolis Liquid Global Markets
Siren
Deerfield Management Company

View all funds holding Structure Therapeutics